A clinical trial to study the effect of two drugs saptaparna bark and chirabilva bark in patients with Kitibha kushta (psoriasis)

A COMPARATIVE CLINICAL EVALUATION OF EFFICACY OF SAPTAPARNA (ALSTONIA SCHOLARIS.R.Br.) BARK AND CHIRABILVA (HOLOPTELIA INTEGRIFOLIA ROXB.PLANCH.) BARK FOR KUSTHAGHNA KARMA VIS-A-VIS TO KITIBHA KUSHTA (PSORIASIS)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046834

Enrollment

Registered

2022-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are willing to be a part of research work. Subjects with chronicity not more than 2yrs. Subjects with mild to moderate disease.

Exclusion criteria

Exclusion criteria: 1.subjects with Kitibha kushta having extracutaneous manifestations. 2.subjects with other systematic disorders like DM,HTN,Asthama. 3.pregnant women and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Classical symptoms of Kitibha kushtaTimepoint: Before treatment -on 0th day During fallow up -on every 15th days After treatment -on 30th day	—

Secondary

Measure	Time frame
Candle grease sign Auspitz sign PASI scoringTimepoint: Before treatment -on 0th day During fallow up -on every 15th days After treatment -on 30th day	—

Countries

India

Contacts

Public ContactDr Mamatha Sri S

Government Ayurveda medical college Bangalore

mamathasri.ayu@gmail.com9886010633

Outcome results